微生态制剂治疗肝硬化肠功能紊乱患者的临床观察

目的探讨微生态制剂治疗肝硬化肠功能紊乱患者的疗效。方法选择80例肝硬化肠功能紊乱患者,随机分成治疗组和对照组。治疗组:常规保肝治疗加金双歧(4粒/次,2次/d);对照组:常规保肝治疗。疗程均为4周。结果治疗组和对照组相比,腹胀、腹泻、腹部不适症状明显改善,血氨水平降低,血浆内毒素水平下降,2组相比差异有显著性(P<0.05)。结论微生态制剂对于改善肝硬化患者临床症状有肯定的价值,并可降低血氨及血浆内毒素水平,有利于肝功能的改善。

Clinical observation of microecologic treatment for the functional intestinal disorder patients with liver cirrhosis

Objective To investigate the curative effect of microecologic treatment for the functional intestinal disorder patients with liver cirrhosis.Methods 80 patients of intestinal disorde with liver cirrhosis were allocted randomly into 2 groups,the treatment group and control group.Patients in treatment group received conventional treatment Jin Shuang qi 4 tablet Bid;Patients in control group received conventional protecting treatment,the course of therapy was four weeks.Results Siginificant differences(P<0.05) existed between 2 groups in the clinical sympotom changes,blood ammonia levels falls and plasma endotoxin levels falls.Conclusion Microecologic treatment are definitely beneficial to the patients of liver cirrhosis with intestinal disorder and showed that the plasma endotoxin levels and blood ammonia levels fallen.